ALMS - Alumis Inc. Common Stock
NEXT EARNINGS:
Mar 18, 2026
(in 21 days)
EPS Est: $-0.90
|
Rev Est: $2.8M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$37.50
DETAILS
HIGH:
$50.00
LOW:
$32.00
MEDIAN:
$37.00
CONSENSUS:
$37.50
UPSIDE:
33.55%
Market Cap:
2.93B
Volume:
1,070,450
Avg Volume:
2,973,516
52 Week Range:
2.76-30.6
Sector:
Healthcare
Industry:
Biotechnology
Beta:
-2.03
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
168
IPO Date:
2021-02-22
EPS (TTM):
-10.38
P/E Ratio:
-0.76
Revenue (TTM):
N/A
Total Assets:
340.99M
Total Debt:
30.72M
Cash & Equiv:
169.53M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-103.7%
Debt/Equity:
0.12
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-13 | $-1.06 | $-0.92 | -15.2% | $2.1M | $2.8M | -24.9% |
| 2025-08-13 | $-1.17 | $-1.11 | -5.4% | $2.7M | $3.1M | -15.2% |
| 2025-05-14 | $-1.82 | $-1.47 | -23.8% | $17.4M | $1.7M | +943.3% |
| 2025-03-19 | $-0.23 | $-1.40 | +83.6% | $1.5M | $1.0M | +51.8% |
| 2024-11-13 | $-1.73 | $-1.64 | -5.5% | — | — | — |
| 2024-08-13 | $-23.10 | $-4.50 | -413.3% | — | — | — |
| 2024-03-31 | $-0.96 | — | — | — | — | — |
| 2023-12-31 | $-4.50 | — | — | — | — | — |
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Net Income | (294.23M) | (154.99M) | (111.93M) |
| EPS | -10.38 | -2.99 | -14.93 |
| Total Assets | 340.99M | 89.61M | 108.17M |
| Total Debt | 30.72M | 32.58M | 1.78M |
| Cash & Equivalents | 169.53M | 46.00M | 25.61M |
| Operating Cash Flow | (255.08M) | (129.97M) | (107.72M) |
| Free Cash Flow | (256.81M) | (134.47M) | (110.13M) |
| FCF per Share | -9.06 | -2.59 | -14.69 |
| Book Value | 260.10M | (339.26M) | (195.24M) |
| Cash & ST Investments | 288.26M | 48.95M | 92.86M |
| ROC Equity | -1.13 | N/A | N/A |